![Reid Huber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reid Huber
Director/Board Member at
RAPPORT THERAPEUTICS, INC.
Net worth: 850 068 $ as of 30/06/2026
Profile
Reid M.
Huber is Director at Tango Therapeutics Sub, Inc. since 2019, Director at Asher Biotherapeutics, Inc. since 2021, Director at Synnovation Therapeutics, Inc., Director at Terremoto Biosciences, Inc. since 2021, Independent Director at Rapport Therapeutics, Inc. since 2022, and Partner at Third Rock Ventures LLC since 2018.
Former roles include Chief Executive Officer at Merida Biosciences, Inc., Chief Executive Officer & Director at MOMA Therapeutics, Inc. from 2020 to 2021, Independent Director at Bellicum Pharmaceuticals, Inc. from 2014 to 2024, Director at American Cancer Society, Inc., Director at Insitro, Inc., Independent Director at Cargo Therapeutics, Inc. from 2023 to 2025, Independent Director at Tango Therapeutics, Inc. from 2019 to 2023, Chief Scientific Officer & Executive VP at Incyte Corp.
from 2014 to 2018, and Principal Research Scientist at DuPont Pharmaceuticals Co. from 1998 to 2002.
Education includes an undergraduate degree from Murray State University (Kentucky) conferred in 1994 and a doctorate from Washington University School of Medicine conferred in 1998.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 20,400 ( 0.04% ) | 850 068 $ | 30/06/2026 |
Reid Huber active positions
| Companies | Position | Start |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Director/Board Member | 01/02/2022 |
Synnovation Therapeutics, Inc.
 Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which develops novel small molecule targeted therapies for oncology and immunology | Director/Board Member | - |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Director/Board Member | 01/08/2021 |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Board Member | 01/03/2021 |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Director/Board Member | 08/07/2019 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01/12/2018 |
Former positions of Reid Huber
| Companies | Position | End |
|---|---|---|
| CARO THERPAR | Director/Board Member | 19/08/2025 |
| BELLICUM PHARMACEUTICALS, INC. | Director/Board Member | 23/02/2024 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | 01/11/2023 |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Reid Huber
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
Murray State University (Kentucky)
 Murray State University (Kentucky) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Synnovation Therapeutics, Inc.
Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which develops novel small molecule targeted therapies for oncology and immunology | Health Technology |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
- Stock Market
- Insiders
- Reid Huber
